
|Articles|April 23, 2012
Thomson Reuters to Sell Healthcare Business to Veritas Capital
Advertisement
Read the full story:
Source: ModernHealthcare.com
Thomson Reuters plans to sell its healthcare business to Veritas Capital for $1.25 billion in cash.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM
4
FAQ: Prior Authorization Reform—Will Changes Go Far Enough by 2027?
5




